Target intelligence / Profile preview

DDR1 divergent transcript (DDR1-DT)

Target
DDR1-DT
Molecular classification
Other (non-coding RNA gene)
01

Overview

**DDR1 divergent transcript (DDR1-DT)** is a non-coding RNA gene located in the vicinity of the DDR1 gene on chromosome 6p21.33[3][7]. It is also called DDR1-AS1 (DDR1 antisense RNA 1), TIGD1L, bPG70P20.2, bCX111D4.7, and bQB10J12.1[1][3]. Unlike the protein-coding DDR1 gene, which encodes the discoidin domain receptor 1 — a receptor tyrosine kinase involved in collagen signaling, cell adhesion, and tumor biology[2][4][5][6][8] — DDR1-DT is not known to encode a functional protein and is not considered a therapeutic target. Its biological function is not described in the current scientific literature, and it has no established role as a disease gene, biomarker, or drug target[7]. **Key clarification:** - **DDR1 divergent transcript (DDR1-DT)** should not be conflated with **DDR1 (Discoidin domain receptor 1)**, which is a validated receptor tyrosine kinase and recognized oncology drug target[4][5][8]. - There is no evidence that DDR1-DT is a receptor, enzyme, transporter, or other classical drug target.

Other names
bPG70P20.2bCX111D4.7bQB10J12.1TIGD1LDDR1-AS1
02

Mechanism of action

None known; not a protein or enzyme, so no mechanism of action for drug interaction is described.

03

Biological functions

Unknown; presumed to be a non-coding RNA, so may play a role in gene regulation, such as antisense regulation or other RNA-mediated processes, but no experimentally validated function has been described
04

Disease associations

No evidence for a direct disease role; not established as an oncogene, tumor suppressor, or other disease-associated factor in the literature or gene function databases
05

Safety considerations

None reported; not a therapeutic target or drug-interaction protein.
06

Interacting drugs

None known; no evidence for direct drug targeting
07

Biomarkers

None known; not currently used clinically or experimentally as a biomarker

Beyond the preview

Go deeper on DDR1 divergent transcript (DDR1-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DDR1 divergent transcript (DDR1-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call